2024-04-012025-03-312025-03-31false06913813Danescroft Dental Practice Limited2025-12-18falseiso4217:GBPxbrli:pure069138132024-03-31069138132025-03-31069138132024-04-012025-03-31069138132023-03-31069138132024-03-31069138132023-04-012024-03-3106913813bus:SmallEntities2024-04-012025-03-3106913813bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3106913813bus:FullAccounts2024-04-012025-03-3106913813bus:PrivateLimitedCompanyLtd2024-04-012025-03-3106913813core:WithinOneYear2025-03-3106913813core:AfterOneYear2025-03-3106913813core:WithinOneYear2024-03-3106913813core:AfterOneYear2024-03-3106913813core:ShareCapital2025-03-3106913813core:SharePremium2025-03-3106913813core:RevaluationReserve2025-03-3106913813core:OtherReservesSubtotal2025-03-3106913813core:RetainedEarningsAccumulatedLosses2025-03-3106913813core:ShareCapital2024-03-3106913813core:SharePremium2024-03-3106913813core:RevaluationReserve2024-03-3106913813core:OtherReservesSubtotal2024-03-3106913813core:RetainedEarningsAccumulatedLosses2024-03-3106913813core:LandBuildings2025-03-3106913813core:PlantMachinery2025-03-3106913813core:Vehicles2025-03-3106913813core:FurnitureFittings2025-03-3106913813core:OfficeEquipment2025-03-3106913813core:NetGoodwill2025-03-3106913813core:IntangibleAssetsOtherThanGoodwill2025-03-3106913813core:ListedExchangeTraded2025-03-3106913813core:UnlistedNon-exchangeTraded2025-03-3106913813core:LandBuildings2024-03-3106913813core:PlantMachinery2024-03-3106913813core:Vehicles2024-03-3106913813core:FurnitureFittings2024-03-3106913813core:OfficeEquipment2024-03-3106913813core:NetGoodwill2024-03-3106913813core:IntangibleAssetsOtherThanGoodwill2024-03-3106913813core:ListedExchangeTraded2024-03-3106913813core:UnlistedNon-exchangeTraded2024-03-3106913813core:LandBuildings2024-04-012025-03-3106913813core:PlantMachinery2024-04-012025-03-3106913813core:Vehicles2024-04-012025-03-3106913813core:FurnitureFittings2024-04-012025-03-3106913813core:OfficeEquipment2024-04-012025-03-3106913813core:NetGoodwill2024-04-012025-03-3106913813core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106913813core:ListedExchangeTraded2024-04-012025-03-3106913813core:UnlistedNon-exchangeTraded2024-04-012025-03-3106913813core:MoreThanFiveYears2024-04-012025-03-3106913813core:Non-currentFinancialInstruments2025-03-3106913813core:Non-currentFinancialInstruments2024-03-3106913813dpl:CostSales2024-04-012025-03-3106913813dpl:DistributionCosts2024-04-012025-03-3106913813core:LandBuildings2024-04-012025-03-3106913813core:PlantMachinery2024-04-012025-03-3106913813core:Vehicles2024-04-012025-03-3106913813core:FurnitureFittings2024-04-012025-03-3106913813core:OfficeEquipment2024-04-012025-03-3106913813dpl:AdministrativeExpenses2024-04-012025-03-3106913813core:NetGoodwill2024-04-012025-03-3106913813core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106913813dpl:GroupUndertakings2024-04-012025-03-3106913813dpl:ParticipatingInterests2024-04-012025-03-3106913813dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3106913813core:ListedExchangeTraded2024-04-012025-03-3106913813dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3106913813core:UnlistedNon-exchangeTraded2024-04-012025-03-3106913813dpl:CostSales2023-04-012024-03-3106913813dpl:DistributionCosts2023-04-012024-03-3106913813core:LandBuildings2023-04-012024-03-3106913813core:PlantMachinery2023-04-012024-03-3106913813core:Vehicles2023-04-012024-03-3106913813core:FurnitureFittings2023-04-012024-03-3106913813core:OfficeEquipment2023-04-012024-03-3106913813dpl:AdministrativeExpenses2023-04-012024-03-3106913813core:NetGoodwill2023-04-012024-03-3106913813core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3106913813dpl:GroupUndertakings2023-04-012024-03-3106913813dpl:ParticipatingInterests2023-04-012024-03-3106913813dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3106913813core:ListedExchangeTraded2023-04-012024-03-3106913813dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3106913813core:UnlistedNon-exchangeTraded2023-04-012024-03-3106913813core:NetGoodwill2025-03-3106913813core:IntangibleAssetsOtherThanGoodwill2025-03-3106913813core:LandBuildings2025-03-3106913813core:PlantMachinery2025-03-3106913813core:Vehicles2025-03-3106913813core:FurnitureFittings2025-03-3106913813core:OfficeEquipment2025-03-3106913813core:AfterOneYear2025-03-3106913813core:WithinOneYear2025-03-3106913813core:ListedExchangeTraded2025-03-3106913813core:UnlistedNon-exchangeTraded2025-03-3106913813core:ShareCapital2025-03-3106913813core:SharePremium2025-03-3106913813core:RevaluationReserve2025-03-3106913813core:OtherReservesSubtotal2025-03-3106913813core:RetainedEarningsAccumulatedLosses2025-03-3106913813core:NetGoodwill2024-03-3106913813core:IntangibleAssetsOtherThanGoodwill2024-03-3106913813core:LandBuildings2024-03-3106913813core:PlantMachinery2024-03-3106913813core:Vehicles2024-03-3106913813core:FurnitureFittings2024-03-3106913813core:OfficeEquipment2024-03-3106913813core:AfterOneYear2024-03-3106913813core:WithinOneYear2024-03-3106913813core:ListedExchangeTraded2024-03-3106913813core:UnlistedNon-exchangeTraded2024-03-3106913813core:ShareCapital2024-03-3106913813core:SharePremium2024-03-3106913813core:RevaluationReserve2024-03-3106913813core:OtherReservesSubtotal2024-03-3106913813core:RetainedEarningsAccumulatedLosses2024-03-3106913813core:NetGoodwill2023-03-3106913813core:IntangibleAssetsOtherThanGoodwill2023-03-3106913813core:LandBuildings2023-03-3106913813core:PlantMachinery2023-03-3106913813core:Vehicles2023-03-3106913813core:FurnitureFittings2023-03-3106913813core:OfficeEquipment2023-03-3106913813core:AfterOneYear2023-03-3106913813core:WithinOneYear2023-03-3106913813core:ListedExchangeTraded2023-03-3106913813core:UnlistedNon-exchangeTraded2023-03-3106913813core:ShareCapital2023-03-3106913813core:SharePremium2023-03-3106913813core:RevaluationReserve2023-03-3106913813core:OtherReservesSubtotal2023-03-3106913813core:RetainedEarningsAccumulatedLosses2023-03-3106913813core:AfterOneYear2024-04-012025-03-3106913813core:WithinOneYear2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106913813core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3106913813core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3106913813core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3106913813core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3106913813core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3106913813core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3106913813core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3106913813core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3106913813core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3106913813core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3106913813core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3106913813core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3106913813core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3106913813core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3106913813core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3106913813core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3106913813core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3106913813core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3106913813bus:Director12024-04-012025-03-3106913813bus:Director22024-04-012025-03-3106913813bus:Director32024-04-012025-03-31

Danescroft Dental Practice Limited

Registered Number
06913813
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

Danescroft Dental Practice Limited
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Dr Adam Hussain
Dr Isaac Hussain
Mrs Jacqueline Hussain

Company Secretary

Mrs Jacqueline Hussain

Registered Address

Fulford Lodge 1 Heslington Lane
Fulford
York
YO10 4HW

Registered Number

06913813 (England and Wales)
Danescroft Dental Practice Limited
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets382,42698,911
Tangible assets490,17986,117
172,605185,028
Current assets
Stocks51,2501,250
Debtors6250,761339,214
Cash at bank and on hand667,084607,312
919,095947,776
Creditors amounts falling due within one year7(707,999)(772,983)
Net current assets (liabilities)211,096174,793
Total assets less current liabilities383,701359,821
Provisions for liabilities8(22,374)(16,204)
Net assets361,327343,617
Capital and reserves
Called up share capital22
Profit and loss account361,325343,615
Shareholders' funds361,327343,617
The financial statements were approved and authorised for issue by the Board of Directors on 18 December 2025, and are signed on its behalf by:
Dr Adam Hussain
Director
Dr Isaac Hussain
Director
Mrs Jacqueline Hussain
Director

Registered Company No. 06913813
Danescroft Dental Practice Limited
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year-end date is recognised by reference to the stage of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Land and buildings20
Plant and machinery20
Vehicles20
Office Equipment20
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year75
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 24329,700329,700
At 31 March 25329,700329,700
Amortisation and impairment
At 01 April 24230,789230,789
Charge for year16,48516,485
At 31 March 25247,274247,274
Net book value
At 31 March 2582,42682,426
At 31 March 2498,91198,911
4.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Office Equipment

Total

£££££
Cost or valuation
At 01 April 244,32257,657104,7884,980171,747
Additions-24,145-2,46126,606
At 31 March 254,32281,802104,7887,441198,353
Depreciation and impairment
At 01 April 242,90643,50637,7241,49485,630
Charge for year-22,544--22,544
At 31 March 252,90666,05037,7241,494108,174
Net book value
At 31 March 251,41615,75267,0645,94790,179
At 31 March 241,41614,15167,0643,48686,117
5.Stocks

2025

2024

££
Raw materials and consumables1,2501,250
Total1,2501,250
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables21,13356,059
Amounts owed by group undertakings229,628277,580
Other debtors-5,575
Total250,761339,214
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables51,23725,891
Amounts owed to related parties320,000350,000
Taxation and social security62,79768,010
Other creditors271,791326,476
Accrued liabilities and deferred income2,1742,606
Total707,999772,983
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)22,37416,204
Total22,37416,204
9.Related party transactions
The directors operate a directors loan account with the company. At 31 March 2025 the balance of this loan was £Nil (2024: £Nil). This loan was interest free and repayable upon demand.